# CABAZITAXEL
> **ANDA207693** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-10-26
## Drug
- **FDA Application Number:** ANDA207693
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2022-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207693)
---
*AI Analytics · CC0 1.0*